Focus On Patients With Tp53 Disruption In The Fondazione Italiana Linfomi (Fil) Mcl0208 Trial: Uniform Poor Outcome, Regardless Of Baseline Predictors, Mrd Status And Lenalidomide Maintenance B. Alessandria,S. Ferrero, G. M. Zaccaria,D. Grimaldi, R. Moia,E. Genuardi,M. Ghislieri, C. Favini,A. Di Rocco,A. Re,V. Stefoni, F. Cavallo, C. Boccomini, M. Balzarotti, V. Ruggero Zilioli,M. Gomes Da Silva,L. Arcaini, A. Lia Molinari, F. Ballerini,A. Ferreri, A. Evangelista,S. Cortelazzo, F. Bertoni,D. Rossi, G. Gaidano, M. LadettoHAEMATOLOGICA(2020)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要